Zkusit zdarma
Johnson & Johnson

Johnson & Johnson

JNJ
Cena:
$ 231.29
+1.11 (0.48%)
Valuace
18
Růst
15
Zdraví
81
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?

President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?

15:25 26-05-2026

Don't be too quick to give up on the industry....

Inflation Adjusted Dividend Income: How to Replace $80,000 in Today’s Dollars 20 Years From Now

Inflation Adjusted Dividend Income: How to Replace $80,000 in Today’s Dollars 20 Years From Now

9:32 26-05-2026

A 50-year-old woman planning to retire at 70 on the equivalent of $80,000 in today's purchasing powe...

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market

17:15 25-05-2026

Johnson & Johnson is a leader in the pharmaceutical and medical device markets. Consumers don't usua...

What a $1 Million Dividend Portfolio Actually Pays After Federal AND State Taxes in California

What a $1 Million Dividend Portfolio Actually Pays After Federal AND State Taxes in California

11:19 25-05-2026

A California retiree with a $1 million dividend portfolio earning a 5% blended yield grosses $50,000...

The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

10:27 23-05-2026

A 73-year-old retiree with a $1.2 million dividend portfolio generating $5,400 a month faces a quiet...

Six Boring Blue Chips Generate $54,000 a Year on $920,000 Without a Single 7 Percent Yield Trap

Six Boring Blue Chips Generate $54,000 a Year on $920,000 Without a Single 7 Percent Yield Trap

7:15 22-05-2026

The six names below sit firmly in the conservative-to-moderate tier. Five are Dividend Kings or Aris...

Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

18:46 21-05-2026

In the latest trading session, Johnson & Johnson (JNJ) closed at $231.73, marking a +1.05% move from...

A $400,000 Income Portfolio That Pays Like a Toledo Rental Property Without the 3 AM Phone Calls

A $400,000 Income Portfolio That Pays Like a Toledo Rental Property Without the 3 AM Phone Calls

7:37 21-05-2026

A single-family rental property in Toledo purchased for $135,000 at a 9% gross cap rate would genera...

A Monthly Dividend Portfolio That Pays Like a Pension and Beats Most Pensions on Inflation Protection

A Monthly Dividend Portfolio That Pays Like a Pension and Beats Most Pensions on Inflation Protection

6:59 21-05-2026

A traditional defined-benefit pension paying $5,500 per month, or $66,000 annually, provides a usefu...

Johnson & Johnson says nipocalimab approved in China

Johnson & Johnson says nipocalimab approved in China

4:31 21-05-2026

Johnson & ‌Johnson's nipocalimab ​has ​won ⁠approval ​in China, ​the U.S. ​drugmaker ...

3 Dividend Aristocrats to Own For a Lifetime Of Passive Income

3 Dividend Aristocrats to Own For a Lifetime Of Passive Income

13:45 20-05-2026

Paychecks stop. Bonuses get cut....

Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

14:20 19-05-2026

Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript...

J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

12:21 19-05-2026

J&J's expanding pipeline, new drug approvals and rising sales from cancer medicines are expected to ...

This Will Be Johnson and Johnson's Stock Price in 2027

This Will Be Johnson and Johnson's Stock Price in 2027

10:21 19-05-2026

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) closed the most recent session at $230.42, up 2....

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

10:01 19-05-2026

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth k...

Meet the Dividend King With a Higher Credit Rating Than the U.S. Government

Meet the Dividend King With a Higher Credit Rating Than the U.S. Government

7:30 19-05-2026

Johnson & Johnson's business can perform well under the most challenging conditions. The company's c...

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

12:47 18-05-2026

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...

Is JNJ Overvalued? DCF Says Worth $122

Is JNJ Overvalued? DCF Says Worth $122

7:10 18-05-2026

On May 18, 2026, we delve into the DCF analysis for Johnson and Johnson (JNJ), a company that has sh...

3 Dividend Stocks Warren Buffett Would Buy in a Market Crash

3 Dividend Stocks Warren Buffett Would Buy in a Market Crash

19:30 17-05-2026

A stock market crash doesn't appear imminent, but there's no harm in being prepared. Many investors ...

Bonds Now Make Up Just 8% of the Average Portfolio. What Replaced Them

Bonds Now Make Up Just 8% of the Average Portfolio. What Replaced Them

10:11 17-05-2026

The traditional 60/40 portfolio, 60% stocks and 40% bonds, has been the default retirement allocatio...

close

PHILADELPHIA JURY RETURNS $250,000 VERDICT AGAINST J&J IN LATEST BABY POWDER-OVARIAN CANCER TRIAL

13-02-2026
PHILADELPHIA--(BUSINESS WIRE)--A JURY IN THE PHILADELPHIA COURT OF COMMON PLEAS HAS FOUND JOHNSON & ...
Více zde

JOHNSON & JOHNSON TO PARTICIPATE IN THE BARCLAYS 28TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

09-02-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) WILL PRESENT AT THE BARCLAYS 28T...
Více zde

JOHNSON & JOHNSON PRESENTS EARLY OUTCOMES FROM THE OMNY-AF PILOT STUDY AT 2026 AF SYMPOSIUM

06-02-2026
IRVINE, CALIF.--(BUSINESS WIRE)--JOHNSON & JOHNSON ANNOUNCED 12-MONTH PILOT-PHASE DATA FROM THE OMNY...
Více zde

JOHNSON & JOHNSON LAUNCHES THE FIRST AND ONLY DAILY DISPOSABLE MULTIFOCAL TORIC CONTACT LENS FOR ASTIGMATIC PATIENTS WITH PRESBYOPIA IN UNITED KINGDOM AND IRELAND

03-02-2026
WORLD'S #1 SELLING CONTACT LENS BRAND ACUVUE®*1 BRINGS PIONEERING INNOVATION FOR ASTIGMATIC PATIENT...
Více zde

JOHNSON & JOHNSON TO PARTICIPATE IN THE TD COWEN 46TH ANNUAL HEALTH CARE CONFERENCE

02-02-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) WILL PRESENT AT THE TD COWEN 46T...
Více zde

JOHNSON & JOHNSON RECEIVES CHMP POSITIVE OPINION FOR AKEEGA® (NIRAPARIB AND ABIRATERONE ACETATE DUAL ACTION TABLET) FOR THE TREATMENT OF PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) WITH BRCA1/2 MUTATIONS

30-01-2026
AMPLITUDE IS THE FIRST CLINICAL TRIAL TO EVALUATE POTENTIAL THERAPIES FOR PATIENTS WITH MHSPC AND KN...
Více zde

DARZALEX FASPRO®-BASED QUADRUPLET REGIMEN APPROVED IN THE U.S. FOR NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA WHO ARE TRANSPLANT INELIGIBLE

27-01-2026
QUADRUPLET REGIMEN DEMONSTRATED SIGNIFICANTLY DEEPER AND MORE DURABLE RESPONSES, HIGHER MRD NEGAT...
Více zde

JOHNSON & JOHNSON MARKS $100 MILLION OF MEDTECH PRODUCTS DONATED SINCE 2020 TO HELP PEOPLE LIVE, SEE AND SMILE

27-01-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON, WITH SUPPORT FROM THE JOHNSON & JOHNSON (J&...
Více zde

PLAINTIFFS' EVIDENCE WILL BE HEARD IN CASES ALLEGING J&J'S TALC PRODUCTS CAUSED WOMEN'S OVARIAN CANCER, ANNOUNCED LEVIN PAPANTONIO ATTORNEY CHRIS TISI

21-01-2026
PENSACOLA, FLA., JAN. 21, 2026 (GLOBE NEWSWIRE) -- A U.S. DISTRICT COURT SPECIAL MASTER IN THE TALC ...
Více zde

JOHNSON & JOHNSON REPORTS Q4 AND FULL-YEAR 2025 RESULTS

21-01-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) TODAY ANNOUNCED RESULTS FOR FOUR...
Více zde

TECVAYLI® MONOTHERAPY DEMONSTRATES SUPERIOR PROGRESSION-FREE AND OVERALL SURVIVAL VERSUS STANDARD OF CARE AS EARLY AS FIRST RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA PREDOMINANTLY REFRACTORY TO ANTI-CD38 THERAPY AND LENALIDOMIDE

14-01-2026
TECVAYLI® ALONE REDUCED RISK OF DISEASE PROGRESSION OR DEATH BY 71% IN A HIGH UNMET NEED POPULATION...
Více zde

JOHNSON & JOHNSON ELEVATES LEADERSHIP IN DEPRESSION WITH NEW DATA AT 2026 AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING

13-01-2026
NEW CAPLYTA ® (LUMATEPERONE) PHASE 3 ANALYSES EVALUATING EFFICACY IN ACHIEVING REMISSION IN ADJUNCT...
Více zde

RYBREVANT® (AMIVANTAMAB-VMJW) LONGER-TERM RESULTS SHOW PROMISING AND DURABLE RESPONSES IN DIFFICULT-TO-TREAT COLORECTAL CANCER

10-01-2026
OVER 70 PERCENT OF PATIENTS IN THE FIRST-LINE SUBGROUP RESPONDED TO AMIVANTAMAB PLUS CHEMOTHERAPY WI...
Více zde

JOHNSON & JOHNSON REACHES AGREEMENT WITH U.S. GOVERNMENT TO IMPROVE ACCESS TO MEDICINES AND LOWER COSTS FOR MILLIONS OF AMERICANS; DELIVERS ON U.S. MANUFACTURING AND INNOVATION INVESTMENTS

08-01-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) (THE “COMPANY”), HEALTHCARE'...
Více zde

JOHNSON & JOHNSON SUBMITS OTTAVA™ ROBOTIC SURGICAL SYSTEM TO THE U.S. FOOD AND DRUG ADMINISTRATION

07-01-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON TODAY ANNOUNCED THAT THE COMPANY HAS SUBMITT...
Více zde

JOHNSON & JOHNSON UNVEILS NEW DATA SHOWING NIPOCALIMAB IS THE FIRST AND ONLY INVESTIGATIONAL FCRN BLOCKER WITH POTENTIAL TO REDUCE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) ACTIVITY IN A PHASE 2 STUDY

06-01-2026
THE JASMINE STUDY MET THE PRIMARY ENDPOINT AND KEY SECONDARY AND EXPLORATORY ENDPOINTS, INCLUDING TH...
Více zde

JOHNSON & JOHNSON SUBMITS APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR TECVAYLI®▼ (TECLISTAMAB) IN COMBINATION WITH DARZALEX® (DARATUMUMAB) SUBCUTANEOUS FORMULATION FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

06-01-2026
NOVEL IMMUNOTHERAPY COMBINATION REGIMEN BRINGS TOGETHER TWO COMPLEMENTARY THERAPIES TO IMPROVE OUTCO...
Více zde

JOHNSON & JOHNSON ANNOUNCES QUARTERLY DIVIDEND FOR FIRST QUARTER 2026

02-01-2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) TODAY ANNOUNCED THAT ITS BOARD O...
Více zde

JOHNSON & JOHNSON COMPLETES ACQUISITION OF HALDA THERAPEUTICS AND ITS NOVEL PLATFORM TO REVOLUTIONIZE CANCER TREATMENT AND ENABLE NEXT-GENERATION ORAL THERAPIES

29-12-2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) (THE “COMPANY”) TODAY ANNOUN...
Více zde

OVER $1.5 BILLION BALTIMORE VERDICT HOLDS JOHNSON & JOHNSON LIABLE OVER ICONIC BABY POWDER

22-12-2025
BALTIMORE--(BUSINESS WIRE)--A BALTIMORE CITY JURY HAS RETURNED A VERDICT IN FAVOR OF CHERIE A. CRAFT...
Více zde

MINNESOTA JURY DELIVERS $65.5 MILLION HISTORY-MAKING VERDICT AGAINST JOHNSON & JOHNSON

19-12-2025
ST. PAUL, MINN.--(BUSINESS WIRE)--A MINNESOTA JURY AWARDED $65.5 MILLION TO A 37-YEAR-OLD MOTHER OF ...
Více zde

JOHNSON & JOHNSON RECEIVES FDA APPROVAL FOR TRUFILL N‑BCA LIQUID EMBOLIC SYSTEM FOR THE TREATMENT OF SYMPTOMATIC CHRONIC SUBDURAL HEMATOMA

18-12-2025
- TRUFILL N-BCA IS NOW INDICATED FOR EMBOLIZATION OF THE MIDDLE MENINGEAL ARTERY (MMA) FOR THE TREA...
Více zde

U.S. FDA APPROVAL OF RYBREVANT FASPRO™ (AMIVANTAMAB AND HYALURONIDASE-LPUJ) ENABLES THE SIMPLEST, SHORTEST ADMINISTRATION TIME FOR A FIRST-LINE COMBINATION REGIMEN WHEN COMBINED WITH LAZCLUZE® (LAZERTINIB)

17-12-2025
RYBREVANT FASPRO™, THE FIRST AND ONLY SUBCUTANEOUS THERAPY FOR PATIENTS WITH EGFR-MUTATED NSCLC, R...
Více zde

JOHNSON & JOHNSON TO HOST INVESTOR CONFERENCE CALL ON FOURTH-QUARTER RESULTS

15-12-2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) WILL HOST A CONFERENCE CALL FOR ...
Více zde

CALIFORNIA JURY AWARDS $40 MILLION IN LANDMARK TALC VERDICT AGAINST JOHNSON & JOHNSON

14-12-2025
LOS ANGELES--(BUSINESS WIRE)--A LOS ANGELES SUPERIOR COURT JURY ON FRIDAY DELIVERED A $40 MILLION VE...
Více zde

CALIFORNIA JURY AWARDS $40 MILLION IN LANDMARK TALC VERDICT AGAINST JOHNSON & JOHNSON

12-12-2025
LOS ANGELES--(BUSINESS WIRE)--A LOS ANGELES SUPERIOR COURT JURY TODAY DELIVERED A $40 MILLION VERDIC...
Více zde

U.S. FDA APPROVES AKEEGA® AS THE FIRST PRECISION THERAPY FOR BRCA2-MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER WITH 54% REDUCTION IN DISEASE PROGRESSION VS STANDARD OF CARE*

12-12-2025
EXPANDED INDICATION FOR AKEEGA® (NIRAPARIB AND ABIRATERONE ACETATE DUAL-ACTION TABLET) PLUS PREDNIS...
Více zde

UNPRECEDENTED RESULTS FROM THE PHASE 3 MAJESTEC-3 STUDY SUPPORT TECVAYLI® PLUS DARZALEX FASPRO® AS A POTENTIAL STANDARD OF CARE AS EARLY AS SECOND LINE FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

09-12-2025
TECVAYLI® AND DARZALEX FASPRO® COMBINATION LED TO A STATISTICALLY SIGNIFICANT PROGRESSION-FREE SUR...
Více zde

JOHNSON & JOHNSON TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

08-12-2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--JOHNSON & JOHNSON (NYSE: JNJ) WILL PRESENT AT THE 44TH ANNUAL ...
Více zde

EARLIER USE OF CARVYKTI® DEMONSTRATED LASTING TREATMENT-FREE REMISSIONS AT 2.5 YEARS IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

06-12-2025
FOLLOW-UP DATA FROM CARTITUDE-4 SHOW AT LEAST 80 PERCENT OF AS-TREATED STANDARD-RISK PATIENTS REMAIN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-11 00:00:0010-KStáhnout
2026-01-21 00:00:008-KStáhnout
2025-10-22 01:00:0010-QStáhnout
2025-10-22 00:00:0010-QStáhnout
2025-10-14 01:00:008-KStáhnout
2025-10-14 00:00:008-KStáhnout
2025-09-09 01:00:008-KStáhnout
2025-09-09 00:00:008-KStáhnout
2025-07-24 01:00:0010-QStáhnout
2025-07-24 00:00:0010-QStáhnout
2025-07-16 01:00:008-KStáhnout
2025-07-16 00:00:008-KStáhnout
2025-06-10 01:00:008-KStáhnout
2025-06-10 00:00:008-KStáhnout
2025-04-30 01:00:008-KStáhnout
2025-04-30 00:00:008-KStáhnout
2025-04-23 01:00:0010-QStáhnout
2025-04-23 00:00:0010-QStáhnout
2025-04-15 01:00:008-KStáhnout
2025-04-15 00:00:008-KStáhnout
2025-04-03 01:00:008-KStáhnout
2025-04-03 00:00:008-KStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-02-20 00:00:008-KStáhnout
2025-02-19 23:00:008-KStáhnout
2025-02-13 00:00:0010-KStáhnout
2025-02-12 23:00:0010-KStáhnout
2025-01-22 00:00:008-KStáhnout
2025-01-21 23:00:008-KStáhnout
2024-10-23 01:00:0010-QStáhnout
2024-10-23 00:00:0010-QStáhnout
2024-10-15 01:00:008-KStáhnout
2024-10-15 00:00:008-KStáhnout
2024-09-20 01:00:008-KStáhnout
2024-09-20 00:00:008-KStáhnout
2024-09-10 01:00:008-KStáhnout
2024-09-10 00:00:008-KStáhnout
2024-08-26 01:00:008-KStáhnout
2024-08-26 00:00:008-KStáhnout
2024-07-25 01:00:0010-QStáhnout
2024-07-25 00:00:0010-QStáhnout
2024-07-17 01:00:008-KStáhnout
2024-07-17 00:00:008-KStáhnout
2024-05-20 01:00:008-KStáhnout
2024-05-20 00:00:008-KStáhnout
2024-05-17 01:00:008-KStáhnout
2024-05-17 00:00:008-KStáhnout
2024-05-01 01:00:008-KStáhnout
2024-05-01 01:00:0010-QStáhnout
2024-05-01 00:00:008-KStáhnout
2024-05-01 00:00:0010-QStáhnout
2024-04-16 01:00:008-KStáhnout
2024-04-16 00:00:008-KStáhnout
2024-02-16 00:00:0010-KStáhnout
2024-02-15 23:00:0010-KStáhnout
2024-01-23 00:00:008-KStáhnout
2024-01-22 23:00:008-KStáhnout
2023-12-05 00:00:008-KStáhnout
2023-12-04 23:00:008-KStáhnout
2023-11-30 00:00:008-KStáhnout
2023-11-29 23:00:008-KStáhnout
2023-11-27 00:00:008-KStáhnout
2023-11-26 23:00:008-KStáhnout
2023-10-27 01:00:0010-QStáhnout
2023-10-27 00:00:0010-QStáhnout
2023-10-23 01:00:008-KStáhnout
2023-10-23 00:00:008-KStáhnout
2023-10-17 01:00:008-KStáhnout
2023-10-17 00:00:008-KStáhnout
2023-08-30 01:00:008-KStáhnout
2023-08-30 00:00:008-KStáhnout
2023-08-25 01:00:008-KStáhnout
2023-08-25 00:00:008-KStáhnout
2023-07-31 01:00:0010-QStáhnout
2023-07-31 00:00:0010-QStáhnout
2023-07-28 01:00:008-KStáhnout
2023-07-28 00:00:008-KStáhnout
2023-07-24 01:00:008-KStáhnout
2023-07-24 00:00:008-KStáhnout
2023-07-20 01:00:008-KStáhnout
2023-07-20 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-01 01:00:008-KStáhnout
2023-05-01 00:00:008-KStáhnout
2023-04-28 01:00:0010-QStáhnout
2023-04-28 00:00:0010-QStáhnout
2023-04-18 01:00:008-KStáhnout
2023-04-18 00:00:008-KStáhnout
2023-04-04 01:00:008-KStáhnout
2023-04-04 00:00:008-KStáhnout
2023-04-03 01:00:008-KStáhnout
2023-04-03 00:00:008-KStáhnout
2023-02-16 00:00:0010-KStáhnout
2023-02-15 23:00:0010-KStáhnout
2023-02-14 00:00:008-KStáhnout
2023-02-13 23:00:008-KStáhnout
2023-01-24 00:00:008-KStáhnout
2023-01-23 23:00:008-KStáhnout
2022-12-22 00:00:008-KStáhnout
2022-12-21 23:00:008-KStáhnout
2022-12-01 00:00:008-KStáhnout
2022-11-30 23:00:008-KStáhnout
2022-11-01 00:00:008-KStáhnout
2022-10-31 23:00:008-KStáhnout
2022-10-27 01:00:0010-QStáhnout
2022-10-27 00:00:0010-QStáhnout
2022-10-18 01:00:008-KStáhnout
2022-10-18 00:00:008-KStáhnout
2022-09-14 01:00:008-KStáhnout
2022-09-14 00:00:008-KStáhnout
2022-07-29 01:00:0010-QStáhnout
2022-07-29 00:00:0010-QStáhnout
2022-07-19 01:00:008-KStáhnout
2022-07-19 00:00:008-KStáhnout
2022-04-29 01:00:008-KStáhnout
2022-04-29 01:00:0010-QStáhnout
2022-04-29 00:00:008-KStáhnout
2022-04-29 00:00:0010-QStáhnout
2022-04-19 01:00:008-KStáhnout
2022-04-19 00:00:008-KStáhnout
2022-02-17 00:00:0010-KStáhnout
2022-02-16 23:00:0010-KStáhnout
2022-02-16 00:00:008-KStáhnout
2022-02-15 23:00:008-KStáhnout
2022-02-02 00:00:008-KStáhnout
2022-02-01 23:00:008-KStáhnout
2022-01-25 00:00:008-KStáhnout
2022-01-24 23:00:008-KStáhnout
2022-01-06 00:00:008-KStáhnout
2022-01-05 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-14 23:00:008-KStáhnout
2021-10-29 01:00:0010-QStáhnout
2021-10-29 00:00:0010-QStáhnout
2021-10-19 01:00:008-KStáhnout
2021-10-19 00:00:008-KStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-08-20 01:00:008-KStáhnout
2021-08-20 00:00:008-KStáhnout
2021-07-29 01:00:0010-QStáhnout
2021-07-29 00:00:0010-QStáhnout
2021-07-21 01:00:008-KStáhnout
2021-07-21 00:00:008-KStáhnout
2021-06-01 01:00:008-KStáhnout
2021-06-01 00:00:008-KStáhnout
2021-04-30 01:00:0010-QStáhnout
2021-04-30 00:00:0010-QStáhnout
2021-04-26 01:00:008-KStáhnout
2021-04-26 00:00:008-KStáhnout
2021-04-20 01:00:008-KStáhnout
2021-04-20 00:00:008-KStáhnout
2021-02-22 00:00:0010-KStáhnout
2021-02-21 23:00:0010-KStáhnout
2021-01-26 00:00:008-KStáhnout
2021-01-25 23:00:008-KStáhnout
2020-12-03 00:00:008-KStáhnout
2020-12-02 23:00:008-KStáhnout
2020-11-03 00:00:008-KStáhnout
2020-11-02 23:00:008-KStáhnout
2020-10-23 01:00:0010-QStáhnout
2020-10-23 00:00:0010-QStáhnout
2020-10-13 01:00:008-KStáhnout
2020-10-13 00:00:008-KStáhnout
2020-10-01 01:00:008-KStáhnout
2020-10-01 00:00:008-KStáhnout
2020-08-25 01:00:008-KStáhnout
2020-08-25 00:00:008-KStáhnout
2020-08-12 01:00:008-KStáhnout
2020-08-12 00:00:008-KStáhnout
2020-07-24 01:00:0010-QStáhnout
2020-07-24 00:00:0010-QStáhnout
2020-07-16 01:00:008-KStáhnout
2020-07-16 00:00:008-KStáhnout
2020-06-10 01:00:008-KStáhnout
2020-06-10 00:00:008-KStáhnout
2020-04-29 01:00:008-KStáhnout
2020-04-29 01:00:0010-QStáhnout
2020-04-29 00:00:008-KStáhnout
2020-04-29 00:00:0010-QStáhnout
2020-04-14 01:00:008-KStáhnout
2020-04-14 00:00:008-KStáhnout
2020-02-18 00:00:0010-KStáhnout
2020-02-17 23:00:0010-KStáhnout
2020-02-13 00:00:008-KStáhnout
2020-02-12 23:00:008-KStáhnout
2020-01-22 00:00:008-KStáhnout
2020-01-21 23:00:008-KStáhnout
2019-12-30 00:00:008-KStáhnout
2019-12-29 23:00:008-KStáhnout
2019-12-05 00:00:008-KStáhnout
2019-12-04 23:00:008-KStáhnout
2019-10-28 00:00:0010-QStáhnout
2019-10-27 23:00:0010-QStáhnout
2019-10-23 01:00:008-KStáhnout
2019-10-23 00:00:008-KStáhnout
2019-10-15 01:00:008-KStáhnout
2019-10-15 00:00:008-KStáhnout
2019-10-07 01:00:008-KStáhnout
2019-10-07 00:00:008-KStáhnout
2019-08-26 01:00:008-KStáhnout
2019-08-26 00:00:008-KStáhnout
2019-07-29 01:00:0010-QStáhnout
2019-07-29 00:00:0010-QStáhnout
2019-07-16 01:00:008-KStáhnout
2019-07-16 00:00:008-KStáhnout
2019-05-01 01:00:0010-QStáhnout
2019-05-01 00:00:0010-QStáhnout
2019-04-26 01:00:008-KStáhnout
2019-04-26 00:00:008-KStáhnout
2019-04-16 01:00:008-KStáhnout
2019-04-16 00:00:008-KStáhnout
2019-04-01 01:00:008-KStáhnout
2019-04-01 00:00:008-KStáhnout
2019-03-21 00:00:008-KStáhnout
2019-03-20 23:00:008-KStáhnout
2019-02-20 00:00:0010-KStáhnout
2019-02-19 23:00:0010-KStáhnout
2019-01-22 00:00:008-KStáhnout
2019-01-21 23:00:008-KStáhnout
2019-01-17 00:00:008-KStáhnout
2019-01-16 23:00:008-KStáhnout
2018-12-17 00:00:008-KStáhnout
2018-12-16 23:00:008-KStáhnout
2018-10-31 00:00:0010-QStáhnout
2018-10-30 23:00:0010-QStáhnout
2018-10-23 01:00:008-KStáhnout
2018-10-23 00:00:008-KStáhnout
2018-10-16 01:00:008-KStáhnout
2018-10-16 00:00:008-KStáhnout
2018-10-02 01:00:008-KStáhnout
2018-10-02 00:00:008-KStáhnout
2018-08-02 01:00:0010-QStáhnout
2018-08-02 00:00:0010-QStáhnout
2018-07-17 01:00:008-KStáhnout
2018-07-17 00:00:008-KStáhnout
2018-06-22 01:00:008-KStáhnout
2018-06-22 00:00:008-KStáhnout
2018-05-14 01:00:008-KStáhnout
2018-05-14 00:00:008-KStáhnout
2018-05-01 01:00:0010-QStáhnout
2018-05-01 00:00:0010-QStáhnout
2018-04-30 01:00:008-KStáhnout
2018-04-30 00:00:008-KStáhnout
2018-04-17 01:00:008-KStáhnout
2018-04-17 00:00:008-KStáhnout
2018-03-20 00:00:008-KStáhnout
2018-03-19 23:00:008-KStáhnout
2018-02-21 00:00:0010-KStáhnout
2018-02-20 23:00:0010-KStáhnout
2018-01-23 00:00:008-KStáhnout
2018-01-22 23:00:008-KStáhnout
2017-12-21 00:00:008-KStáhnout
2017-12-20 23:00:008-KStáhnout
2017-11-13 00:00:008-KStáhnout
2017-11-12 23:00:008-KStáhnout
2017-11-09 00:00:008-KStáhnout
2017-11-08 23:00:008-KStáhnout
2017-11-02 00:00:0010-QStáhnout
2017-11-01 23:00:0010-QStáhnout
2017-10-17 01:00:008-KStáhnout
2017-10-17 00:00:008-KStáhnout
2017-10-02 01:00:008-KStáhnout
2017-10-02 00:00:008-KStáhnout
2017-08-03 01:00:0010-QStáhnout
2017-08-03 00:00:0010-QStáhnout
2017-07-18 01:00:008-KStáhnout
2017-07-18 00:00:008-KStáhnout
2017-06-16 01:00:008-KStáhnout
2017-06-16 00:00:008-KStáhnout
2017-05-08 01:00:0010-QStáhnout
2017-05-08 00:00:0010-QStáhnout
2017-05-01 01:00:008-KStáhnout
2017-05-01 00:00:008-KStáhnout
2017-04-18 01:00:008-KStáhnout
2017-04-18 00:00:008-KStáhnout
2017-03-03 00:00:008-KStáhnout
2017-03-02 23:00:008-KStáhnout
2017-02-27 00:00:0010-KStáhnout
2017-02-26 23:00:0010-KStáhnout
2017-02-01 00:00:008-KStáhnout
2017-01-31 23:00:008-KStáhnout
2017-01-24 00:00:008-KStáhnout
2017-01-23 23:00:008-KStáhnout
2016-11-04 00:00:0010-QStáhnout
2016-11-03 23:00:0010-QStáhnout
2016-10-18 01:00:008-KStáhnout
2016-10-18 00:00:008-KStáhnout
2016-09-19 01:00:008-KStáhnout
2016-09-19 00:00:008-KStáhnout
2016-08-04 01:00:0010-QStáhnout
2016-08-04 00:00:0010-QStáhnout
2016-07-19 01:00:008-KStáhnout
2016-07-19 00:00:008-KStáhnout
2016-07-18 01:00:008-KStáhnout
2016-07-18 00:00:008-KStáhnout
2016-06-03 01:00:008-KStáhnout
2016-06-03 00:00:008-KStáhnout
2016-05-20 01:00:008-KStáhnout
2016-05-20 00:00:008-KStáhnout
2016-05-10 01:00:0010-QStáhnout
2016-05-10 00:00:0010-QStáhnout
2016-05-02 01:00:008-KStáhnout
2016-05-02 00:00:008-KStáhnout
2016-04-19 01:00:008-KStáhnout
2016-04-19 00:00:008-KStáhnout
2016-03-01 00:00:008-KStáhnout
2016-02-29 23:00:008-KStáhnout
2016-02-24 00:00:0010-KStáhnout
2016-02-23 23:00:0010-KStáhnout
2016-01-25 23:00:008-KStáhnout
2016-01-18 23:00:008-KStáhnout
2015-10-29 23:00:0010-QStáhnout
2015-10-13 00:00:008-KStáhnout
2015-10-09 00:00:008-KStáhnout
2015-10-05 00:00:008-KStáhnout
2015-09-28 00:00:008-KStáhnout
2015-07-31 00:00:0010-QStáhnout
preloader